Howard Goldsweig

Sensor Platforms, Inc. develops algorithms and software platforms that enable smart phone and tablet apps to understand user contexts and intents. Its FreeMotion Library makes sensor fusion and user context awareness available in smartphones and tablets to combine and process data from installed sensors and microprocessors to better interpret users movements and situations and infer their intents. The company was founded by David M. Traversi, George Hsu and Herbert M. Dwight Jr. in 2004 and is headquartered in San Jose, CA.

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

K2M, Inc. manufactures and markets medical devices. It offers deformity correction systems, spinal stabilization systems, lateral access systems, minimally invasive systems, and, constrained and translational cervical plates. The company was founded by John Philip Kostuik and Eric Major in January 2004 and is headquartered in Leesburg, VA.

Achronix Semiconductor Corp. offers high-density and high-performance application-targeted field programmable gate arrays. Its products include Speedster22i HD, Speedster22i HP, ACE, Boards, Documentation and Video Demos. The firm also offers the Achronix CAD environment (ACE), an easy-to-use, mature, robust design-tool suite for its customers and ACE includes integrated support for industry-standard synthesis tools Synplify Pro and Precision Synthesis. The company was founded by John Lofton Holt, Rajit Manohar, Virantha N. Ekanayake, and Clinton W. Kelly VI in 2004 and is headquartered in Santa Clara, CA.

Ferric, Inc. develops integrated circuits and integrated inductors in CMOS technology for use in on-chip voltage regulators. Its products include chips and circuit IP, power management IC, packaged integrated voltage regulators and stack integrated voltage regulators. The firm offers power converters utilizing inductors. Its technology can be applies across a broad spectrum of power electronics ranging from full scale servers to the chip level. The company was founded in 2011 by Noah Sturcken, Maurizio Arienzo and Kenneth Shepard and is headquartered in New York, NY.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom.

TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA.

BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

Brightvolt Solid State Batteries provides embedded power solutions. It also develops custom solid state thin film batteries and power solutions for client’s IoT devices; flexion solid state thin film lithium polymer batteries; and thin micro electronics. The company was founded by Robert Singleton and Craig Nelson in 2001 and is headquartered in Redmond, WA.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark.

Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.

zeotap GmbH offers a solution for telecom operators. It provides a technology platform that transmits data securely and in a privacy-compliant way for businesses and consumers. The company was founded by Daniel Heer, Stephan Schwebe and Projjol Banerjea and is headquartered in Berlin, Germany.

NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.

Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom.

Pakal Technologies, Inc. provides and designs next generation of IGTO power devices. The company is headquartered in San Francisco, CA.

Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.